Royalty Report: Supply, Medical, collagen – Collection: 920


Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Supply
  • Medical
  • collagen
  • implants
  • Device
  • Drugs
  • Pharmaceuticals

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 920

License Grant
Licensor grants an exclusive right and license, with the right to grant sublicenses, under the licensed patents and licensed technology to develop, manufacture or have manufactured, use, offer for sale, sell and import licensed products.
Field of Use
The licensed products are proprietary information, including patents and trade secrets relating to self-expandable collagen implants, which are designed to be delivered to anatomical sites for various therapeutic purposes, including cardiovascular indications, and the methods for manufacturing such collagen implants and the techniques and apparatus used for delivering such collagen implants to the anatomical sites.

IPSCIO Record ID: 26152

License Grant
Licensor grants the sole and exclusive license to manufacture, use and sell the collagen meniscus implant (CMI) product within the territory.

Licensor grants the right to grant sublicenses for the CMI Product within the territory.

In addition, Licensor grants the exclusive license to use trade marks and trade names applicable to the CMI Product in the territory.

License Property
“CMI Product” shall mean that collagen meniscus implant product.

The Collagen Meniscus Implant (CMI®) is a biological and completely absorbable implant made from highly purified collagen with a porous structure.

Field of Use
Licensor is engaged in the development of a collagen meniscus implant (“CMI”) for the treatment of knee injuries involving the meniscus

The product is a collagen meniscus implant (CMI) for the treatment of knee injuries involving the meniscus.

IPSCIO Record ID: 3752

License Grant
The Licensor hereby grants to the Licensee an exclusive, irrevocable, right and License, with the right to subLicense the Intellectual Property and the Joint Intellectual Property, including the right to use or have used, make or have made, market, have marketed, offer for sale, import for sale, and sell and have sold any product of process covered by the Licensor's Patent(s) and/or any Joint Patent(s) in the field of medical collagen bioprosthesis.
License Property
Licensor has technical expertise in woven textile production and manufacturing; and whereas, the Parties desire to collaborate to jointly develop commercial production processes for fabricating woven and/or braided NDGA-treated collagen fiber bioprostheses.
Field of Use
The rights granted apply to the field of medical collagen bioprosthesis.  Licensee has technical expertise in producing NDGA-treated collagen fibers suitable for medical implants, such as braided or woven collagen implants, and owns or has exclusive rights to patents and patent applications covering NDGA-treated collagen and implants.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.